Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Format:	Artykuł
Język:	English
Wydane:	American Association for the Advancement of Science (AAAS) 2020-01-01
Seria:	Research
Dostęp online:	http://dx.doi.org/10.34133/2020/1458090

Podobne zapisy

Ureteral stent technology: Drug-eluting stents and stent coatings
od: Luo Yang, i wsp.
Wydane: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
od: Josep Gomez‐Lara, i wsp.
Wydane: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
od: E. Y. Zagorulko, i wsp.
Wydane: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
od: Yusuke Tsukada, i wsp.
Wydane: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
od: Qing Ma, i wsp.
Wydane: (2021-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
od: Hang Ouyang, i wsp.
Wydane: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
od: Jing Wang, i wsp.
Wydane: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
od: Walid Maamoun
Wydane: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
od: А. Н. Кудряшов, i wsp.
Wydane: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
od: Paweł Gąsior, i wsp.
Wydane: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
od: Yang O, i wsp.
Wydane: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
od: Juntao Yin, i wsp.
Wydane: (2023-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
od: Yi-Xing Yang, i wsp.
Wydane: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
od: I. Rykowska, i wsp.
Wydane: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
od: Hongxia Li, i wsp.
Wydane: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
od: Michał Hawranek, i wsp.
Wydane: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
od: Zhu, Xiaoxiang, i wsp.
Wydane: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
od: Masaki Hirose, i wsp.
Wydane: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
od: Matthew G. Whitbeck, i wsp.
Wydane: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
od: Ahmed Abdelaziz, i wsp.
Wydane: (2024-11-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
od: Zoltán-István Szabó, i wsp.
Wydane: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
od: Nina Peng, i wsp.
Wydane: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
od: Ng, Anthony Herr Cheun
Wydane: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
od: Maciej Koźlik, i wsp.
Wydane: (2023-02-01)

Drug-eluting stents: long-term safety
od: Yu A Karpov, i wsp.
Wydane: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
od: Imad Sheiban, i wsp.
Wydane: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
od: Sohila Refahi, i wsp.
Wydane: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
od: Xiao-Fang Tang, i wsp.
Wydane: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
od: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Wydane: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
od: Jonathan Hanna, i wsp.
Wydane: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
od: Cheng-Hsuan Tsai, i wsp.
Wydane: (2022-06-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
od: Ali S. Almasood, i wsp.
Wydane: (2011-01-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
od: Yinping Zhao, i wsp.
Wydane: (2021-02-01)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
od: Spadaccio Cristiano, i wsp.
Wydane: (2016-01-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
od: Fong, Timothy Ren Zhong
Wydane: (2015)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
od: Sacharias von Koch, i wsp.
Wydane: (2024-12-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
od: Iraj Jafaripour, i wsp.
Wydane: (2023-05-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
od: Porto, I, i wsp.
Wydane: (2005)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
od: Yi-Xing Yang, i wsp.
Wydane: (2023-01-01)

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon in Left Main Coronary Artery Disease
od: Rong-Xue Xiao, i wsp.
Wydane: (2022-04-01)